A shorter, and less toxic treatment for people with visceral leishmaniasis was shown to be effective thanks to a study conducted in Eastern Africa by the non-profit medical research organization Drugs for Neglected Diseases ...
Sep 29, 2022
0
10
The first case of concomitant visceral leishmaniasis and non-ulcerated cutaneous leishmaniasis in the same patient has been reported recently by researchers at the Federal University of São Carlos (UFSCar) in São Paulo ...
Aug 8, 2023
0
4
Current treatment options for the parasitic disease leishmaniasis are largely ineffective, expensive, and tend to be plagued by resistant parasites and side effects. Now, researchers reporting in PLOS Neglected Tropical Diseases ...
Dec 6, 2018
0
0
Togo had reason to celebrate in 2022 when it became the first country in the world to eliminate four neglected tropical diseases. The west African nation stamped out Guinea worm disease in 2011, lymphatic filariasis in 2017, ...
Jan 27, 2023
0
4
A new study conducted in Nepal highlights household hygiene as key to eliminating visceral leishmaniasis, a disfiguring and often fatal disease caused by the Leishmania donovani parasite that is transmitted by the bite of ...
Mar 30, 2020
0
0
The results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative (DNDi), in partnership with Médecins Sans Frontières (MSF), the University of Gondar, and Addis Ababa University, open ...
Jan 17, 2019
0
1
A drug that has already been approved for treatment of tuberculosis could also be a powerful tool to combat another of the developing world's major diseases, researchers at the University of Dundee have found.
May 25, 2016
0
4
Research involving scientists at the University of York has provided important new information about transmission of human leishmaniasis, a group of infectious diseases which kills more than 100,000 people a year.
Jan 16, 2014
0
0
One form of the disease begins with large open sores that won't heal, then migrates to the nose and lips, rotting them away like a form of leprosy and leaving the victim badly disfigured.
Jun 7, 2018
1
1
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat ...
Feb 23, 2012
0
0
